PAR-25-065-Full-Announcement.html

This document is a full announcement for the "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)" federal grant opportunity, Solicitation Number PAR-25-065.

The funding opportunity is sponsored by the Department of Health and Human Services National Institutes of Health, specifically the National Institute of Mental Health (NIMH) and the National Institute on Aging (NIA). The goal is to encourage studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the intent of advancing understanding of biobehavioral and neurobiological pathways and informing novel therapeutic development. Eligible applicants include a range of organizations such as nonprofits, state/local governments, small businesses, and tribal entities. The opportunity is funded under the NIMH's Mental Health Research Grants program (CFDA 93.242) and the NIA's Aging Research program (CFDA 93.866). No other details on award amounts, response deadlines, or award timelines are provided in this announcement.